As a dedicated manufacturer and supplier of specialty chemicals, we understand the importance of providing consistent, high-quality intermediates for the pharmaceutical industry. 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline (CAS 74852-62-3) is one such vital compound, playing a key role in the synthesis of antifungal medications like Itraconazole. For businesses looking to secure their supply chain, exploring bulk purchase options offers significant advantages.
Why Bulk Purchase Makes Sense
When you purchase 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline in bulk, several benefits emerge:
Key Considerations for Bulk Buyers
When planning a bulk purchase of 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline, prospective buyers should:
We are committed to being a premier supplier of pharmaceutical intermediates. By choosing to buy 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline in bulk from us, you are investing in a reliable, high-quality supply chain that supports your pharmaceutical manufacturing goals. Contact us today to discuss your bulk procurement needs and receive a competitive quote.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.